ArticleEndocrine2018

30mCi radioactive iodine achieving comparative excellent response in intermediate/high-risk nonmetastatic papillary thyroid cancer: a propensity score matching study.

Yingqiang Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.